A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 425-430

  Tillman, David M ^a   Petak, Istvan ^a   Houghton, Janet A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FLUOROURACIL; FOLINIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANTIGENS, CD95; CELL DIVISION; COLONIC NEOPLASMS; DRUG SYNERGISM; FAS LIGAND PROTEIN; FLUOROURACIL; HT29 CELLS; HUMANS; INTERFERON TYPE II; LEUCOVORIN; MEMBRANE GLYCOPROTEINS; NEUROPEPTIDES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033044686     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Houghton, J. A., Harwood, F. G., and Tillman, D. M. Thymineless death in colon carcinoma cells is mediated via Fas signalling. Proc. Natl. Acad. Sci. USA, 94: 8144-8149, 1997.
2. Houghton, J. A., Harwood, F. G., Gibson, A. A., and Tillman, D. M. The Fas signaling pathway is functional in colon carcinoma cells and induces apoptosis. Clin. Cancer Res., 1: 723-730, 1997.
3. Tillman, D. M., Harwood, F. G., Gibson, A. A., and Houghton, J. A. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells. Cell Death Diff., 5: 450-457, 1998.
4. von Reyher, V., Strater, J., Kittstein, W., Gschwendt, M., Krammer, P. H., and Moller, P. Colon carcinoma cells use different mechanisms to escape CD95-induced apoptosis. Cancer Res., 58: 526-534, 1998.
5. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell, 75: 1169-1178, 1993.
6. Moller, P., Koretz, K., Leithauser, F., Bruderlein, S., Henne, C., Quentmeier, A., and Krammer, P. Expression of Apo-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57: 371-377, 1994.
7. Benz, C., and Cadman, E. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Cancer. Res., 41: 994-999, 1981.
8. Geoffroy, F. J., Allegra, C. J., Sinha, B., and Grem, J. L. Enhanced cytotoxicity with interleukin-1α and 5-fluorouracil in HCT116 colon cancer cells. Oncol. Res., 6: 581-591, 1994.
9. Evans, R. M., Laskin, J. D., and Hakala M. T. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. Cancer Res., 40: 4113-4122, 1980.
10. Rubin, B. Y., and Gupta, S. L. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc. Natl. Acad. Sci. USA, 77: 5928-5932, 1980.
11. Houghton, J. A., Morton, C. L., Adkins, D. A., and Rahman, A. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-α2a in colon carcinoma cells. Cancer Res., 53: 4243-4250, 1993.
12. Houghton, J. A., Cheshire, P. J., Morton, C. L., and Stewart, C. F. Potentiation of 5-fluorouracil-leucovorin activity by α2a-interferon in colon adenocarcinoma xenografts. Clin. Cancer Res., 1: 33-40, 1995.
13. Wadler, S., Wersto, R., Weinberg, V., Thompson, D., and Schwartz, E. L. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res., 50: 5735-5739, 1990.
14. Ismail, A-S. A., van Groningen, C. J., Hardcastle, A., Ren, Q-F., Aherne, G. W., Geoffrey, F., Allegra, C. J., and Grem, J. L. Modulation of fluorouracil cytotoxicity by interferon-α and -γ. Mol. Pharmacol., 53: 252-261, 1998.
15. Wadler, S., Schwartz, E. L., Goldman, M., Lyver, A., Rader, M., Zimmerman, M., Itri, L., Weinberg, V., and Wiernik, P. H. 5-Fluorouracil and recombinant α2a-interferon: an active regimen against colorectal carcinoma. J. Clin. Oncol., 7: 1769-1775, 1989.
16. Grem, J. L., Chu, E., Boarman, D., Balis, F. M., Murphy, R. F., McAtee, N., and Allegra, C. J. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations. Semin. Oncol., 19 (Suppl 13): 36-44, 1992.
17. Chu, E., Koeller, D. M., Johnston, P. E., Zinn, S., and Allegra, C. J. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-γ. Mol. Pharmacol., 43: 527-533, 1993.
18. Schiller, J. H., and Brittner, G. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines. Int. J. Cancer, 46: 61-66, 1990.
19. Branca, A. A., and Baglioni, C. Evidence that types I and II interferons have different receptors. Nature, 294: 768-770, 1981.
20. Brunda, M. J., and Wright, R. B. Differential antiproliferative effects of combination of recombinant interferon α and γ-1b on two murine tumor cell lines. Int. J. Cancer, 37: 287-291, 1986.
21. Houghton, J. A., Williams, L. G., Loftin, S. K., Cheshire, P. J., Morton, C. L., Houghton, P. J., Dayan, A., and Jolivet, J. Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts. Cancer Chemother. Pharmacol., 30: 423-432, 1992.
22. Houghton, J. A., Houghton, P. J., and Wooten, R. S. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2′-deoxyuridine. Cancer Res., 30: 2406-2413, 1979.
23. Cheshire, J. L., and Baldwin, A. S. Synergistic activation of NF-κB by tumor necrosis factor α and γ interferon via enhanced IκBα degradation and de nova IκBκ degradation. Mol. Cell. Biol., 17: 6746-6754, 1997.
24. Shao, R. G., Cao, C. X., Shimizu, T., O, Connor, P. M., Kohn, K. W., and Pommier, Y. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-O1) in human cancer cell lines, possibly influenced by p53 function. Cancer Res., 57: 4029-4035, 1997.
25. Fearon, E. R., and Vogelstein, B. A. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990.